Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SkinHealth Systems Inc. (SKIN) Cash Flow Statement

SkinHealth Systems Inc. (SKIN) generated $22.0M of operating cash flow over the twelve months to 2026-06-30, spent $817000 on capital expenditure and had free cash flow of $21.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SKINSkinHealth Systems Inc.Follow SKIN — free
Household & Personal Products · Consumer Defensive
—
Price chart with a free account
Market cap
—
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-0.03-0.110.020.020.040.02
Capital expenditure0.010.010.000.000.00-0.00
Free cash flow-0.04-0.120.020.020.040.02
Share repurchases0.000.160.030.000.00—
Stock-based compensation0.010.030.020.030.01—

USD billions · SEC XBRL

SkinHealth Systems Inc. — questions

What is SkinHealth Systems Inc.'s operating cash flow?
$22.0M over the twelve months to 2026-06-30.
How much does SkinHealth Systems Inc. spend on capital expenditure?
$817000 over the twelve months to 2026-06-30.
What is SkinHealth Systems Inc.'s free cash flow?
$21.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from SkinHealth Systems Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.